Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Medifast (MED) Tops Q4 EPS by 26c, Offers Guidance
February 23, 2022 4:56 PM ESTMedifast (NYSE: MED) reported Q4 EPS of $2.91, $0.26 better than the analyst estimate of $2.65. Revenue for the quarter came in at $377.8 million versus the consensus estimate of $375.79 million.
GUIDANCE:
Medifast sees FY2022 EPS of $14.50-$16.00, versus the consensus of $15.96. Medifast sees... More

